TET1 and gastric cancer: Our data also showed that low expression of TET1 or FOXO4 predicts poor survival of gastric cancer patients, suggesting that reactivation of TET1 or FOXO4 might be a novel therapeutic approach to prevent gastric cancer metastasis.